TERT and hepatocellular carcinoma: TERT promoter mutations appear in 6% of low-grade dysplastic nodules (LGDNs) and 19% of high-grade dysplastic nodules (HGDNs), and the frequency of TERT promoter mutations dramatically increases in early HCC (61%) and remains high in advanced and terminal-stage HCC [39].